Evolutionary insights for immunological interventions

Pragmatic Evolution: Applications of Evolutionary Theory

Volumn , Issue , 2011, Pages 115-132

  Ewald, Paul W ^a   Swain Ewald, Holly A ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84929932129     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511980381.012     Document Type: Chapter

References (41)

1. Balkwill, F. 2009. Tumour necrosis factor and cancer. Nature Reviews Cancer 9:361-71.
2. Baud, V. and Karin, M. 2009. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls. Nature Reviews Drug Discoveries 8:33-40.
3. Brooks, G.F. 1969. Recent trends in diphtheria in the United States. Journal of Infectious Disease 120:500-02.
4. Brooks, G.F. and Buchanan, T.M. 1970. Pertussis in the United States. Journal of Infectious Disease 122:123-5.
5. Chapuis, L., Ji, B., Truffot-Pernot, C., et al. 1994. Preventive therapy of tuberculosis with rifapentine in immunocompetent and nude mice. American Journal of Respiratory and Critical Care Medicine 150:1355-62.
6. Chen, R.T., Broome, C.V., Weinstein, R.A., et al. 1985. Diphtheria in the United States, 1971-81. American Journal of Public Health 75:1393-7.
7. Cherry, J.D., Brunell, P.A., Golden, G.S. et al. 1988. Report of the task force on pertussis and pertussis immunization. Pediatrics 82:s939-84.
8. Dieckmann, U. and Metz, H. (Eds). 2002. Virulence Management: Mathematical Models of Virulence Evolution. Cambridge University Press, Cambridge.
9. Dudding, B.A., Top Jr., F.H., Winter, P.E., et al. 1973. Acute respiratory disease in military trainees: the adenovirus surveillance program, 1966-1971. American Journal of Epidemiology 97:187-98.
10. Erdman, D.D., Xum, W., Gerber, S.I., et al. 2002. Molecular epidemiology of adenovirus type 7 in the United States, 1966-2000. Emerging Infectectios Diseases 8:269-77.
11. Ewald, P.W. 1994. Evolution of Infectious Disease. Oxford University Press, New York, NY.
12. Ewald, P.W. 1996. Vaccines as evolutionary tools: the virulence antigen strategy. In: Kaufmann, S.H.E. (Ed.), Concepts in Vaccine Development. de Gruyter, Berlin, pp. 1-25.
13. Ewald, P.W. 2009. An evolutionary perspective on parasitism as a cause of cancer. Advances in Parasitology 68:21-43.
14. Greten, F.R., Arkan, M.C., Bollrath, J., et al. 2007. NF-kappaB is a negative regulator of IL-1beta secretion as revealed by genetic and pharmacological inhibition of IKKbeta. Cell 130:918-31.
15. Hamilton, W.D. 1980. Sex versus nonsex versus parasite. Oikos 35:282-90.
16. Hideshima, T., Chauhan, D., Richardson, P., et al. 2002. NF-kappa B as a therapeutic target in multiple myeloma. Journal of Biological Chemistry 277:16639-47.
17. Hoffmann, A. and Baltimore, D. 2006. Circuitry of nuclear factor kappaB signaling. Immunology Reviews 210:171-86.
18. Hoffmann, A., Levchenko, A., Scott, M.L., et al. 2002. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298:1241-5.
19. Kajon, A.E., Moseley, J.M., Metzgar, D., et al. 2007. Molecular epidemiology of adenovirus type 4 infections in US military recruits in the postvaccination era (1997-2003). Journal of Infectious Diseases 196:67-75.
20. Karin, M., Yamamoto, Y. and Wang, Q.M. 2004. The IKK NF-kappa B system: a treasure trove for drug development. Nature Reviews Drug Discoveries 3:17-26.
21. Lyons, A., Longfield, J., Kuschner, R., et al. 2008. A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults. Vaccine 26:2890-8.
22. Meffert, M.K., Chang, J.M., Wiltgen, B.J., et al. 2003. NF-kappa B functions in synaptic signaling and behavior. Nature Neuroscience 6:1072-8.
23. Metzgar, D., Osuna, M., Kajon, A.E., et al. 2007. Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. Journal of Infectious Diseases 196:1465-73.
24. Miller, L.W., Older, J.J., Drake, J. et al. 1972. Diphtheria immunization. Effect upon carriers and the control of outbreaks. American Journal of Diseases of Children 123:197-199.
25. Mueller, H. 1998. Tumor necrosis factor as an antineoplastic agent: pitfalls and promises. Cellular and Molecular Life Sciences 54:1291-8.
26. Murphy, K., Travers, P. and Walport, M. 2008. Janeway's Immunobiology. 7th edn. Garland, New York, NY.
27. Pappenheimer, A.M. Jr., 1977. Diphtheria toxin. Annual Reviews in Biochemistry 46:69-94.
28. Pappenheimer, A.M. 1982. Diphtheria: studies on the biology of an infectious disease. Harvey Lectures, 76.
29. Pappenheimer, A.M. and Gill, D.M. 1973. Diphtheria. Science 182:353-8.
30. Read, A.F. and Mackinnon, M.J. 2007. Pathogen evolution in a vaccinated world. In: Stearns, S.C. and Koella, J.C. (Eds), Evolution in Health and Disease. 2nd edn. Oxford University Press, New York, NY.
31. Russell, K.L., Broderick, M.P., Franklin, S.E., et al. 2006a. Transmission dynamics and prospective environmental sampling of adenovirus in a military recruit setting. Journal of Infectious Diseases 194:877-85.
32. Russell, K.L., Hawksworth, A.W., Ryan, M.A., et al. 2006b. Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004. Vaccine 24:2835-42.
33. Schmitt, M.P. and Holmes, R.K. 1991. Characterization of a defective diphtheria toxin repressor (dtxR) allele and analysis of dtxR transcription in wild-type and mutant strains of Corynebacterium diphtheriae. Infection and Immunity 59:3903-08.
34. Schmitt, M.P., Twiddy, E.M. and Holmes, R.K. 1992. Purification and characterization of the diphtheria toxin repressor. Proceedings of the National Academy of Science USA 89:7576-80.
35. Sunyer, J.O., Boshra, H., Lorenzo, G., et al. 2003. Evolution of complement as an effector system in innate and adaptive immunity. Immunology Research 27:549-64.
36. Tate, J.E., Bunning, M.L., Lott, L., et al. 2009. Outbreak of severe respiratory disease associated with emergent human adenovirus serotype 14 at a US air force training facility in 2007. Journal of Infectious Diseases 199:1419-26.
37. Top, F.H. Jr., 1975. Control of adenovirus acute respiratory disease in U.S. Army trainees. Yale Journal of Biological Medicine 48:185-95.
38. Trei, J.S., Johns, N.M., Garner, J.L., et al. 2010. Spread of adenovirus to geographically dispersed military installations, May-October 2007. Emerging Infectious Diseases 16:769-75.
39. Uchida, T., Gill, D.M. and Pappenheimer, A.M. 1971. Mutation in the structural gene for diphteria toxin carried by temperate phage β. Nature New Biology 166:908-10.
40. Vora, G.J., Lin, B., Gratwick, K., et al. 2006. Co-infections of adenovirus species in previously vaccinated patients. Emerging Infectious Diseases 12:921-30.
41. Yang, D., Chertov, O. and Oppenheim, J.J. 2001. The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity. Cellular and Molecular Life Science 58:978-89.